Clinical Trials
29 trialsPediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
BWHS RoR
Boston University
HCP
University of Southern California
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Abramson Cancer Center at Penn Medicine
CHARM
Kaiser Permanente
Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study
Ohio State University Comprehensive Cancer Center
Gene-HEART
Abramson Cancer Center at Penn Medicine
LIBER
UNICANCER
LIBRE
Technical University of Munich
Nutritional Intervention and DNA Damage of Patients With HBOC
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Enhance the Use of Genetic Counseling and Testing in Latinas
Georgetown University
Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment
Georgetown University
Statewide Communication to Reach Diverse Low Income Women
University of California, San Francisco
Tissue Expansion in Breast Reconstruction Without Drains
Cedars-Sinai Medical Center
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
GOG Foundation
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
Georgetown University
Genetic Counseling for Breast Cancer Survivors (GC for BC)
H. Lee Moffitt Cancer Center and Research Institute
Genetic Risk: Whether, When, and How to Tell Adolescents
Johns Hopkins University
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
National Cancer Institute (NCI)
Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
Emory University
Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children
Georgetown University
Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)
M.D. Anderson Cancer Center
Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study
Medical University of Vienna
Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
National Cancer Institute (NCI)
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
Sheba Medical Center
Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer
National Cancer Institute (NCI)
EXSAL
Centre Francois Baclesse
Telemedicine vs. Face-to-Face Cancer Genetic Counseling
Duke University
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
The Cleveland Clinic